Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Elena Godbout"'
Autor:
Anna Jirovec, Ashley Flaman, Elena Godbout, Daniel Serrano, Joel Werier, Bibianna Purgina, Jean-Simon Diallo
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Dedifferentiated liposarcoma (DDLS) is an aggressive, recurring sarcoma with limited treatments. T-cell immunotherapies selectively target malignant cells, holding promise against DDLS. The development of successful immunotherapy for DDLS re
Externí odkaz:
https://doaj.org/article/42e4a4db2bd24d3f9f68e73d9674012a
Autor:
Elena Godbout, Dong Ok Son, Stephanie Hume, Stellar Boo, Vincent Sarrazy, Sophie Clément, Andras Kapus, Bernhard Wehrle-Haller, Leena Bruckner-Tuderman, Cristina Has, Boris Hinz
Publikováno v:
Cells, Vol 9, Iss 12, p 2702 (2020)
We identify the focal adhesion protein kindlin-2 as player in a novel mechanotransduction pathway that controls profibrotic cardiac fibroblast to myofibroblast activation. Kindlin-2 is co-upregulated with the myofibroblast marker α-smooth muscle act
Externí odkaz:
https://doaj.org/article/8acc59e3adfa4e7bb9bedafb37f70e51
Autor:
Zaid Taha, Rozanne Arulanandam, Glib Maznyi, Elena Godbout, Madalina E. Carter-Timofte, Naziia Kurmasheva, Line S. Reinert, Andrew Chen, Mathieu J.F. Crupi, Stephen Boulton, Geneviève Laroche, Alexandra Phan, Reza Rezaei, Nouf Alluqmani, Anna Jirovec, Alexandra Acal, Emily E.F. Fekete, Ragunath Singaravelu, Julia Petryk, Manja Idorn, Kyle G. Potts, Hayley Todesco, Cini John, Douglas J. Mahoney, Carolina S. Ilkow, Patrick Giguère, Tommy Alain, Marceline Côté, Søren R. Paludan, David Olagnier, John C. Bell, Taha Azad, Jean-Simon Diallo
Publikováno v:
Taha, Z, Arulanandam, R, Maznyi, G, Godbout, E, Carter-Timofte, M E, Kurmasheva, N, Reinert, L S, Chen, A, Crupi, M J F, Boulton, S, Laroche, G, Phan, A, Rezaei, R, Alluqmani, N, Jirovec, A, Acal, A, Brown, E E F, Singaravelu, R, Petryk, J, Idorn, M, Potts, K G, Todesco, H, John, C, Mahoney, D J, Ilkow, C S, Giguère, P, Alain, T, Côté, M, Paludan, S R, Olagnier, D, Bell, J C, Azad, T & Diallo, J-S 2022, ' Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen ', Molecular Therapy, vol. 30, no. 9, pp. 2998-3016 . https://doi.org/10.1016/j.ymthe.2022.04.025
We established a split nanoluciferase complementation assay to rapidly screen for inhibitors that interfere with binding of the receptor binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d052687f015e890d9f0b9d825f8eed66
https://doi.org/10.1016/j.ymthe.2022.04.025
https://doi.org/10.1016/j.ymthe.2022.04.025